Pl find enclosed unaudited financial results along with LRR for quarter ended 30th June, 2026

<a> ALKEM LABORATORIES LTD. Regd. Office:· ALKEM HOUSE. Senapati Bapat Marg. Lower Pare! (West). Mumbai -400 013. Maharashtra. India. • Phone: +91-22-3982 9999 • Fax: 022-2495 2955 - ALKEM - • Email: contact@alkem.com • Website: www.alkemlabs.com • CIN: L00305MH1973PLC174201 inspiring Healthier Lives 14th August, 2026 The Corporate Relationship Department National Stock Exchange of India BSE Limited Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Mumbai 400 001. Bandra East, ScripCode:539523 Mumbai 400 051. Serio Svmbol: ALKEM Sub: Outcome of the Board Meeting held on 14th August, 2026 Dear Sir(s)/ Madam, This is in reference to our earlier intimation dated 21st July, 2026, pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations"), regarding holding of Board Meeting on 14th August, 2026 to inter alia approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. The Board of Directors at its meeting held today, i.e. 14th August, 2026 has approved the Standalone and Consolidated Unaudited Financial Results of the Company for the qua1ter ended 30th June, 2026. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the SEBI LODR Regulations, is enclosed herewith. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 01 :40 p.m. The above information is also available on the website of the Company at \,\,\VW.alkcmlnbs.corn Kindly take the same on record. Sincerely, For Alkem Laboratories Limited Manish Narang ~ President - Legal, Company Secretary & Compliance Officer Encl.: a/a Deloitte Chartered Accountants One International Center, Haskins & Sells LLP Tower 3, 31st Floor, Senapati Bapat Marg Elphinstone Road (West) Mumbai -400 013 Maharashtra, India Tel: +91 22 6185 6000 Fax: +91 22 6185 4101 INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM CONSOLIDATED FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF ALKEM LABORATORIES LIMITED 1. We have reviewed the accompanying Statement of Consolidated Unaudited Financial Results of Alkem Laboratories Limited ("the Parent") and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group") and its share of the net loss after tax and total comprehensive income of its associate for the quarter ended June 30, 2026 ("the Statement") which includes the branch of the Group located at Nepal, being submitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("the Listing Regulations"). 2. This Statement, which is the responsibility of the Parent's Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India (!CAI). A review of interim financial information consists of making inquiries, primarily of Parent's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable. 4. The Statement includes the results of the entities mentioned in Annexure 1 to this report. 5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the review reports of the other auditors referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. Regd. Office: One International Center, Tower 3, 31st floor, Senapati Bapat Marg, Elphinstone Road (West), Mumbai-400 013, Maharashtra, India. Deloitte Haskins & Sells LLP is registered with Limited Liability having LLP identification No: AAB-8737 Deloitte Haskins & Sells LLP 6. We did not review the interim financial information / financial results of four subsidiaries included in the consolidated unaudited financial results, whose interim financial information / financial results reflect total revenues of Rs. 2,945.1 million for the quarter ended June 30, 2026, total net profit after tax of Rs. 47.8 million for the quarter ended June 30, 2026 and total comprehensive income of Rs. 66.2 million for the quarter ended June 30, 2026, as considered in the Statement. These interim financial information / financial results have been reviewed by other auditors whose reports have been furnished to us by the Management and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries is based solely on the reports of the other auditors and the procedures performed by us as stated in paragraph 3 above. Our conclusion on the Statement is not modified in respect of this matter. 7. The consolidated unaudited financial results includes the interim financial information / financial results of twenty subsidiaries which have not been reviewed by their auditors, whose financial information/ financial results reflect total revenue of Rs. 2,261.9 million for the quarter ended June 30, 2026, total net loss after tax of Rs. 100.6 million for the quarter ended June 30, 2026 and total comprehensive income of Rs. (82. 7) million for the quarter ended June 30, 2026, as considered in the Statement. The consolidated unaudited financial results also includes the Group's share of loss after tax of Rs. 5.1 million for the quarter ended June 30, 2026 and total comprehensive income of Rs. (5.1) million for the quarter ended June 30, 2026, as considered in the Statement, in respect of one associate, based on their interim financial information which have not been reviewed by their auditor. According to the information and explanations given to us by the Management, these interim financial information/ financial results are not material to the Group. Our Conclusion on the Statement is not modified in respect of our reliance on the interim financial information / results certified by the Management. For Deloitte Haskins & Sells LLP Chartered Accountants (Firm's Registration No. 117366W/W-100018) Rupen K. Bhatt (Partner) (Membership No. 046930) (UDIN: 16o/.i6!)30!VZ~Y [Showing first 8,000 characters — download PDF for full document]